Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cerebellar ataxia, Cayman type is characterized by psychomotor retardation, hypotonia and cerebellar dysfunction (nystagmus, ataxic gait, truncal ataxia, dysarthric speech and intention tremor), associated with cerebellar hypoplasia.
Features include always present findings: Shrinkage of the cerebellum (cerebellar atrophy), Ataxia, Hypomimic face, and Pes planus; and very common findings: Strabismus and Nonprogressive cerebellar ataxia. 20 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 10 | Broad-based gait, Truncal ataxia, Slowness of movement (bradykinesia) |
ATCAY encodes ATCAY kinesin light chain interacting caytaxin (371 aa). Functions in the development of neural tissues, particularly the postnatal maturation of the cerebellar cortex. Highest expression in Brain Frontal Cortex BA9 (108.9 TPM) and Brain Cortex (104.7 TPM).
Cayman type cerebellar ataxia is associated with mutations in the ATCAY gene on chromosome 19.
ATCAY is classified as a druggable target (Enzyme category) with score 0.0.
Genetic testing for ATCAY is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 4 always present features, 2 very common features, 12 common features.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
6 publications have been identified in PubMed for Cayman type cerebellar ataxia. Research spans Case Report / Case Series (33%), Epidemiology / Natural History (33%), and Other (17%).
Villa-Lopez M (2025). [PMID: 40537356](https://pubmed.ncbi.nlm.nih.gov/40537356/). *Parkinsonism & related disorders*. [Case Report / Case Series]
Milovanović A (2025). [PMID: 40915867](https://pubmed.ncbi.nlm.nih.gov/40915867/). *Parkinsonism & related disorders*. [Other]
Villa-Lopez M (2025). [PMID: 41198475](https://pubmed.ncbi.nlm.nih.gov/41198475/). *Parkinsonism & related disorders*. [Case Report / Case Series]
Dhar D (2025). [PMID: 38842035](https://pubmed.ncbi.nlm.nih.gov/38842035/). *The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry*. [Review / Meta-Analysis]
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 4:02 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Cayman type cerebellar ataxia
Muscles |
4 |
Skeletal muscle atrophy, Shrinkage of the cerebellum (cerebellar atrophy), Low muscle tone (hypotonia) |
Eyes | 3 | Strabismus, Nystagmus, Abnormal retinal morphology |
Bones and joints | 1 | Skeletal muscle atrophy |
Head and neck | 1 | Hypomimic face |
Age of onset: at birth.
Gogus B (2024). [PMID: 38587696](https://pubmed.ncbi.nlm.nih.gov/38587696/). *Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology*. [Epidemiology / Natural History]